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ABSTRACT
Many patients with liver disease would have to undergo surgery. Surgery and anesthesia in patients with liver 
??????????????????????????????????????????????????????????????????????????? ????????????????????????????????????
????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????
complications are essential to reduce the morbidity and mortality. Surgical risk is increased in patients with liver 
cirrhosis. Child turchote pugh (CTP) and the model for end stage liver disease (MELD) are two scoring systems 
which are often used nowadays to stratify risk factors in patients with liver cirrhosis who will undergo surgery. 
Elective surgery is well tolerated in cirrhosis patients with CTP class A and permissible in patient with CTP 
class B with preoperative preparation, except for extensive liver resection surgery and cardiac surgery. Elective 
surgery is contraindicated in patients with CTP class C, acute viral hepatitis, alcoholic hepatitis, fulminant liver 
failure, and liver disease with severe extrahepatic complication such as hypoxemia, cardiomyopathy, and acute 
renal failure. Intensive monitoring in the postoperative period and early intervention of complications are also 
essential to reduce the morbidity and mortality.
Keywords: surgery, liver disease, perioperative 
ABSTRAK
Pasien-pasien dengan penyakit hati banyak yang menjalani pembedahan. Tindakan pembedahan dan 
prosedur anestesi pada pasien-pasien penyakit hati berhubungan dengan tingginya komplikasi dan kematian 
?????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????
komplikasi preoperatif, intraoperatif, dan postoperative untuk mengurangi morbiditas maupun mortalitas. Risiko 
pembedahan akan meningkat pada pasien sirosis hati. Child turchote pugh (CTP) dan model for end stage liver 
disease (MELD) merupakan sistem skoring yang saat ini digunakan untuk menilai faktor risiko pada pasien 
sirosis yang menjalani pembedahan. Operasi elektif dapat dilakukan pada pasien dengan CTP kelas A dapat 
dilakukan dengan persiapan optimal pada pasien dengan CTP kelas B kecuali pada operasi reseksi hati dan 
operasi jantung. Operasi elektif dikontraindikasikan pada pasien CTP kelas C, hepatitis virus akut, alkoholik 
hepatitis, gagal hati fulminan, dan penyakit hati dengan komplikasi ekstrahepatik berat seperti hipoksemia, 
kardiomiopati, dan gagal hati akut. Monitoring ketat pada kondisi postoperatif serta intervensi awal terhadap 
komplikasi sangat penting untuk menurunkan morbiditas dan mortalitas. 
Kata kunci: operasi, penyakit hati, perioperatif
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INTRODUCTION
Liver has an important role in homeostasis of many 
physiological systems in our body. Liver performs 
many processes such as food and drugs metabolism, 
plasma protein synthesis, coagulation factors synthesis, 
????????????????? ???????????????????? ???????????????
and exogenous substances. It also plays important role 
??????????????????????????????????????????????????????1 
Liver disease comprises a large spectrum of hepatic 
dysfunction. It includes asymptomatic transaminitis, 
cirrhosis, and end-stage liver disease. Liver disease 
can contribute to an increased risk of perioperative 
morbidity and mortality.2
Many patients with liver disease would have to 
undergo surgery. It was estimated that 10% patients 
with liver disease will need surgery in the last two 
years of their life.3 Less invasive surgical techniques 
have made surgery possible for patients with advanced 
liver diseases. Surgery and anesthesia in patients 
with liver disease are associated with extremely high 
perioperative complications and mortality.1 Because 
of the loss of hepatic reserve capacity and other 
systemic derangements which are the result of liver 
dysfunction (such as hemodynamic impairments), 
patients with liver disease have impaired response 
to surgical stress. These individuals consequently 
have increased risk of bleeding, infection, impaired 
wound healing, postoperative hepatic decompensation, 
including hepatic coma or death. Therefore, the 
decision to perform surgery in these patients must be 
considered carefully. Increased perioperative risk also 
correlate with severity of liver diseases. The major 
causes of death are uncontrolled haemorrhage (from 
coagulopathy intraoperatively or variceal bleeding 
postoperatively), sepsis, and multiorgan failure.4
Identification of the type of liver disease, 
stratification of risk factors, and management 
of perioperative complications are important to 
reduce morbidity and mortality intraoperative and 
??????????????? ?????????????? ?????????????? ?????????
history taking and physical examination to detect 
risk factors and evidence of liver dysfunction. Risk 
??????? ?????????????? ??? ????????????? ?????? ?????????? ???
calculated using child turchotte pugh (CTP) score 
and model for end stage liver disease (MELD) score. 
Intensive monitoring in the postoperative period and 
early intervention of complications are essential.5 
This review provides information about preoperative, 
intraoperative, and postoperative procedures in patient 
with liver disease.
EFFECT OF SURGERY & ANESTHESIA DRUGS 
ON THE LIVER
Alteration of Hepatic Blood Flow
Intraoperative hypotension is common in patient 
with liver disease. Factors which contribute to alter of 
?????????????????????????????????????????????????????
which can reduce hepatic perfusion 30-5-% during 
induction procedure; (2) Hyperdinamic circulation and 
altered hepatic arterial buffer in cirrhotic liver; and (3) 
Other factors (bleeding, vasoactive drugs, continuous 
positive pressure ventilation, pneumoperitoneum).1
??????????? ??????????? ??????????? ?????????? ???
patients with liver disease because these drugs have 
????????????????????????????????????????????????????
??????????????????????? ?????????????????????????????
?????????????????????????????????????????????????
oxygen supply to the heart and halothane may also 
increase the risk of drug-induced hepatitis.6
Hipoxemia Effect
Use of anesthesia may increasethe risk of aspiration 
in patients with advanced liver disease that can lead 
to hypoxemia. Other risk factors are encephalopathy, 
ascites, and hepatic hydrothorax.1
EFFECT OF LIVER DECOMPENSATION ON 
ANESTHESIA DRUGS
Liver dysfunction will affect the metabolism of 
drugs used perioperatively through some mechanisms 
which are: (1) Alteration in metabolism by the 
cytochrome P450 enzyme; (2) Decreased concentration 
of plasma protein binding; and (3) Decreasedbiliary 
excretion. All of these three factors will lead to 
increaseddrug toxicity.1
Volatile Agents
Anesthetics inhalation metabolized by liver as much 
??????????????????????????? ?????????????????????? ?
??????????????? ???????????????????? ?????????????????
????????? ????????????????????????????????? ??????????????
inhalation anesthetics.6 Halothane is not recommended 
because the liver metabolism is high. This is due to the 
immune sensitization by proteins that are the result of 
oxidative halothane metabolism by cytochrome P450 
2E1 in people who are predisposed genetically.7
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Intravenous Agents
???????????????????????? ??????????????????????????
anesthetic drug in patients with liver disease because 
propofol has the shortest half life, even in patients with 
decompensated cirrhosis and in several study propofol 
????????????????????????????7
Non-depolarizing Muscle Relaxan
The increased volume of distribution of 
nondepolarizing muscle relaxant drugs in patients 
with liver disease, so that it was required a larger dose 
to achieve the effects of neuromuscular blockade. 
????????????????????????????????????? ??????????????????
patients with liver disease because they are eliminated 
not through the kidneys and liver. For operation with 
long duration such as liver transplantation, doxacurium 
more recommended because their metabolism are 
through the kidneys.8
Sedative, Narcotics & Intravenous Induction
The use of sedatives and narcotics groups in patients 
with compensated liver disease are generally well 
tolerated but should be monitored carefully in patient 
with hepatic disfunction because these drugs may cause 
prolonged suppression of the central nervous system and 
precipitate hepatic encephalopathy. Levels of these drugs 
??????????????????????????????????????????????????????
??????????? ?????????????????????????????????????????????
to the liver in patients with liver dysfunction. Elimination 
of benzodiazepine class drugs which do not undergo 
glucoronidation such as midazolam, diazepam and 
chlordiazepoxide are prolonged in liver disease, so that 
their half life are extended. Lorazepam, oxazepam and 
temazepam, which undergone glucoronidation, do not 
affected by the presence of liver dysfunction. Overall, the 
use of narcotics and benzodiazepines should be avoided 
in patients with liver disfunction. When necessary, an 
???????????????????????????????????????????????????????
recommended as a sedative because their metabolisms 
are not affected by hepatic dysfunction.1 Many types of 
anesthetic management (general anesthesia, regional 
anesthesia, or monitored anesthesia care) did not affect 
mortality, which reported in one of the largest reported 
series (733 patients).9
PREOPERATIVE SCREENING
Perioperative patient screening should include 
careful history taking and physical examination 
to identify risk factors for liver disease. History 
taking includes: (1) Symptoms of chronic liver 
disease (pruritus, fatigue, bleeding, yellowish skin, 
oedema, mental alteration); (2) History of prior blood 
transfusion, jaundice or liver disease, and family history 
of liver disease; (3) History of metabolic diseases such 
as diabetes mellitus, hypertension, hyperlipidemia, 
obesity; (4) History of autoimmune disease such as 
systemic lupus erithematosus, autoimmune thyroid 
disease; and (5) Social history, which includesdrug 
abuse, sexual promiscuity, tattoo, excessive alcohol 
use, use of hepatotoxic medicine and herbal.10
Physical Examination
Cirrhosis may be suspected due to abnormal 
???????????????????????????????? ????????????????????
describes physical signs in liver disease.10
Figure 1. Physical signs in liver disease10, 11
Laboratory & Radiology Testing
Preoperative liver biochemical testing for screening 
in healthy and asymptomatic patient is debatable.8 
Some studies did not recommend biochemical testing 
because it was not cost effective and has low positive 
predictive value.12 Other studies report an incidence of 
6-34% undiagnosed cirrhosis in asymptomatic patients 
with abnormal liver function test results.2 Though not 
performed as part of routine preoperative screening, 
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routine laboratory testing as a part of general medical 
examination for some patients with subclinical liver 
disease, may reveal abnormalities in liver biochemical 
test.12
Laboratory tests which should be evaluated if there 
is a clinical suspicion of liver disease are include: 
(1) Complete blood count; (2) Blood glucose; (3) 
Electrolyte and creatinin serum; (4) Coagulation factor; 
(5) Liver biochemical test (alanine transaminase, 
aspartate transaminase, albumin serum, bilirubin 
serum, alkali phosphatase) (elective surgery should be 
deferred if there is elevation in AST and ALT serum 
greater than three times the upper limit of normal value 
or with any elevation in total bilirubin concentration); 
(6) Serology of viral hepatitis, autoimmune hepatitis, 
and metabolic disease; (7) Examination of ascites, 
which is needed to exclude infection. Radiology tests 
include: (1) Abdominal ultrasonography; (2) Magnetic 
resonance cholangio-pancreatography (MRCP) or 
endoscopic-retrograde cholangio-pancreatography 
(ERCP) which may be considered when biliary 
obstruction is suspected.2
Liver biopsy is a gold standard to diagnose and 
determine severity of liver disease. Patients are at 
acceptable risk of surgery if they are noted to have 
mild-to-moderate histological damage (Stage 0, I, and 
?????????????????????????????????????????????????????
??????????????????????? ????????????????????????? ???????
??????????????????????????????????????????????????????
more cautious approach before surgery.10 If the patient 
has comorbidities, further testing will be necessary.12
Nature of The Underlying Liver Disease
Acute Hepatitis
Patient with acute hepatitis who undergone surgery 
have an increased of operative risk with mortality 
rate 10-13%.12 These increased risks are probably 
occur as a result of the acute hepatocellular injury 
and associated hepatic dysfunction. Acute hepatitis 
should be considered a contraindication to elective 
surgery and surgical intervention should be postponed 
???????????????????????????????????????????????????????
biochemical & histologic parameters) have subsided.2 
In live saving operation, patient with acute hepatitis 
should be monitored closely perioperative.6
Alcoholic Hepatitis
Alcoholic hepatitis is a contraindication to elective 
surgery and will increase the perioperative mortality 
rate greatly after urgent and emergency surgery with 
mortality rate up to 58%. Patients who consume 
alcohol in a long time will have increased tolerance 
to the majority of anesthetic drugs. Reexamination of 
liver function for elective surgery preparation should 
be performed after more than 12 weeks of alcohol 
abstinence. This was done in order to prevent alcohol 
withdrawal as well as an increase in the toxicity of 
acetaminophen and halothan.8
Acute Hepatic Failure
Patients with conditions of acute liver failure 
??????????????????????????????????????????????????????
and hepatic encephalopathy) are contraindicated to 
any type of surgery other than liver transplantation.7
????????????????????
The mortality rate increased by 8-28 % in patients 
with obstructive jaundice who undergone surgery. 
Factors that increase mortality risk include early 
hematocrite < 30 %, total bilirubin > 11mg /dL, 
and malignancy. If this three risk factors occur, the 
mortality rate will increase to 60 % but if none of them 
occur, the mortality rate is < 5 %. Other risk factors 
are creatinine serum > 1.4 mg /dL, albumin serum < 
3 g/dL, age > 65 years, transaminase serum > 90 IU/L 
and BUN > 19 mg/dL.3
Chronic Hepatitis
Surgical risk in patients with chronic hepatitis 
???????? ??? ???? ????????? ??? ?????? ???????????? ????
degree of liver disease. Chronic hepatitis patients with 
??????????????????????????????????????????????????
of hepatic decompensation is not associated with an 
increase surgical risk. However, chronic hepatitis 
?????????????????????????????????????????????????????
necrosis or bridging on liver biopsy) and accompanied 
by hepatic decompensation (impaired liver synthesis, 
excretion, portal hypertension) will have increased 
surgical risk.7
Liver Cirrhosis 
Cirrhosis is a state of decreased systemic vascular 
??????????????????????????????????????????????????????
especially in the presence of portal hypertension. 
Those who have cirrhosis should undergo further 
??????????????????????????????????????????????????????????
portal hypertension, because this increases risk for 
?????????????????????????????????????????????????????????
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hypertension include thrombocytopenia, splenomegaly, 
varices, ascites, and hepatic venous pressure gradient 
greater than 10. 13
Severity of The Liver Disease Associate with 
?????????????
Asymptomatic Patients
?????????????????????? ??????????????????????????
liver function should have their elective surgery 
postponed and their liver disease investigated. Their 
perioperative risk should be reassessed after their liver 
dysfunction is characterized.14
Symptomatic Liver Disease
Elective surgery is contraindicated in patients with 
acute viral hepatitis, alcoholic hepatitis, fulminant liver 
failure, severe coagulopathy, and liver disease with 
severe extrahepatic complication such as hypoxemia, 
cardiomyopathy, and acute renal failure. When these 
contraindications are absent, patient with liver disease 
could undergone through preoperative evaluation, and 
treatment of the liver disease should be optimized 
before elective surgery.8
Surgical risk is increased in patients with liver 
cirrhosis. The magnitude of surgical risk is correlated 
with the degree of hepatic decompensation. Child 
turchote pugh (CTP) and the model for end stage liver 
disease (MELD) are two scoring systems which are 
often used nowadays to assess the severity of liver 
??????????????????????????????????????????????????????????
with liver cirrhosis who will undergone surgery.4,5 
???????????????????????????????????????????????????
are objective (serum bilirubin, serum albumin, and 
prothrombin time) and the other two are subjective (the 
presence of ascites and encephalopathy). CTP score is 
???????????????????????????????????????????????????
with score of 5-6, score 7-9 for CTP class B and score 
10-15 for CTP class C.15
Two multicenter retrospective study reported 
consistent results, in which mortality ratein cirrhotic 
patients who undergone surgery with CTP class A 
was 10 %, 30% in CTP class B % and 76-82 % in 
CTP class C. The general consensus is that elective 
surgery is well tolerated in patients cirrhosis with CTP 
class A, permissible with preoperative preparation in 
patient with CTP class B except those who undergoing 
extensive liver resection surgery and cardiac surgery. 
While the elective surgery in chirrotic patient with CTP 
class C is contraindicated, and nonoperative selection 
is recommended.15
CTP score has several limitations in terms of 
clinical parameters that are subjective as well as the 
determination of cut-off grades used in biochemical 
parameters. The last few years, MELD score (Model 
for End Stage Liver Disease) has used as a prognostic 
factor for operative mortality in patients with liver 
cirrhosis.3 MELD score consist of three biochemical 
variables: creatinine serum, total bilirubin serum and 
INR (International Normalized Ratio).2
A retrospective study conducted by Teh, et al. 
in 772 patients with liver cirrhosis who undergone 
intraabdominal, orthopedic, and cardiovascular surgery 
MELD = 3.78 x loge serum bilirubin (mg/dL) + 11.20 
x loge INR + 9.57 x loge serum creatinine (mg/dL) + 
6.43 (constant for liver disease etiology)
Notes:
If the patient has been dialyzed twice within the 
last 7 days, then the value for serum creatinine used 
should be 4.0
Any value less than one is given a value of 1 (i.e. 
if bilirubin is 0.8, a value of 1.0 is used) to prevent the 
occurrence of scores below 0 (the natural logarithm of 
1 is 0, and any value below 1 would yield a negative 
result)
Table 1. Child-Turcotte-Pugh score16
Component Score
a
1 point 2 points 3 points
Total bilirubin concentration (μmol/L)b ???? ????? ????
Serum albumin concentration (g/L) > 35 28-35 < 28
International normalized ratio ????? ??????? > 2.2
Ascites None Controlled with medication Treatment-refractory
Encephalopathy None Grade I-II (or controlled with medication) ??????????????????????????????????????
a?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????
30-day, 90-day and long-term postoperative mortality 
rate. At 30 days postoperative, patients with MELD 
score less than or equal to 7 had a mortality rate of 
5,7%, patients with MELD score 8-11 had mortality 
rate of 10.3%, and patients with MELD score 12-15 
Figure 2. Model for end stage liver disease (MELD) score2
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had mortality rate of 25.4%. Mortality rate increased 
linearly with the increase in MELD score.17Use of CTP 
score and MELD score are not mutually exclusive 
and can complement each other,however MELD 
score is probably the most precise single predictor for 
perioperative mortality risk.8
ESTIMATING THE RISK FACTOR
????????????????????????????????????? ??????????????????
??? ?????????? ???? ???? ????????? ??? ?????? ????????? ????
Comorbid condition; and (3) Timing & type of surgery.8 
The greatest morbidity and mortality risks are found 
in emergency surgery, intra- abdominal surgery and 
cardiac surgery.3
Henje & Patel have proposed an algorithm for the 
preoperative assessment of patients with liver disease 
based on severity of liver disease.
Timing of Surgery
Emergency Surgery
The results of several studies concluded that patients 
with cirrhosis who undergone emergency surgery 
particularly abdominal surgery or surgery due to trauma 
have a higher mortality rate than patients with normal 
liver function and have correlation with increasing CTP 
score. The mortality rate in cirrhosis patient with CTP 
class A who underwent emergency surgery was 22 %, 
38% in CTP B, and 100% in CTP C.12
Elective Surgery
Elective surgery is contraindicated in several 
clinical scenarios listed in table 2.
Table 2. Contraindication for Elective Procedures in Patients 
with Liver DIsease?
Contraindication for Elective Procedures in Patients with 
Liver Disease
Acute liver failure
Acute renal failure
Acute viral Hepatitis
Alcoholic Hepatitis
Cardiomyopathy
Hypoxemia
Severe coagulopathy (despite treatment)
Patient for whom there are no absolute 
contraindications should undergo individualized risk 
??????????????????????? ????????????? ?????????????????
liver disease, severity of liver disease, and type of 
surgical procedure.13
??????????????????????????????????????????????
Intraabdominal Surgery
Intraabdominal surgery increases morbidity 
and mortality in patients with liver cirrhosis. 
Intraabdominal surgery causesgreater reduction in 
?????? ???? ???? ???? ??????? ??? ??????? ?????? ??????????
Futhermore, intraabdominal surgery increases 
intraoperative bleeding complications due to portal 
hypertension, especially in patients with a history of 
previous intraabdominal surgery and the presence of 
coagulopathy. The mortality rate in patients with liver 
cirrhosis who undergone laparotomy varies between 
20-54%, where emergency surgery has worsenthe 
prognosis and the mortality ratereached 50%. MELD 
score over 14 and serum hemoglobin levels < 10 mg/
dL are the best predictors of increased mortality rate 
in intraabdominal surgery.6
Biliary tract surgery is often performed in patients 
with liver cirrhosis. MELD score < 8 is the cut 
Figure 3: Algorithm for the preoperative assessment of patients with liver disease2
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off to undergone laparoscopic cholecystectomy in 
patients with liver cirrhosis. In general, laparoscopic 
cholecystectomy can be performed in patients 
with CTP class A and in patients with CTP class 
B without portal hypertension. In patients with 
CTP class C, non-operative management are 
preferred. If non-operative management fails,then 
percutaneouscholecystostomyshould be considered.6
Cardiac Surgery
The risk factors of hepatic decompensation after 
cardiac surgery are total bypass time, the use of 
?????????????????????????????????????????????????????
and perioperative vasopressor use. Cardiopulmonary 
bypass may aggravate the coagulopathy in liver 
disease by inducing thrombopathy, fibrinolysis, 
and hypocalcemia.8Patient with liver cirrhosis who 
undergone cardiopulmonary bypass surgery showed 
low mortality rate in CTP A (0 % and 3 %), which 
greatly increased in CTP B (42 % and 50 %) and CTP 
C (100 %). More than 75 % of patients with liver 
cirrhosis with CTP B and C suffered acute liver failure. 
CTP score > 7 and MELD score > 13 are predictors of 
increased mortality in patients with liver cirrhosis who 
undergone cardiac surgery.7
Hepatic Resection Surgery
Patients with liver cirrhosis who undergone liver 
resection procedure showed increased risks of death 
and hepatic decompensation compared to other types of 
surgery. Hepatic resection will reduce compensation of 
remaining functional hepatocytes. One study showed 
the incidence of acute liver failure post liver resection 
is 0% for MELD score < 9, 3.6 % for MELD score 
9-10, and 37.5 % for MELD score> 10.8
PREOPERATIVE COMPLICATION MANAGEMENT
Special considerations should be directed to the 
treatment of complications of chronic liver disease 
such as malnutrition, coagulopathy, thrombocytopenia, 
ascites, renal dysfunction, hepatic encephalopathy, 
esophageal varices, and impaired lung function.7This 
table on below showed complication of liver disease 
and their effect in surgery. 
??????????????????????????????????????????????????????????????6
Liver disease Type of surgery Mortality Prognostic factors
Cirrhosis
Chronic hepatitis
Hepatitis C
Acute hepatitis
Obstructive jaundice
Non laparoscopic billiary surgery
Peptic Ulcer Surgery
Umbilical hernioraphy
Colectomy
Abdominal Surgery for trauma
Emergency abdominal surgery
Laparoscopic cholecystectomy
Emergency cardiac surgery
Elective cardiac surgery
Knee replacement
Transurethral resection of the prostate
?????????????
Laparoscopic cholecystectomy
Exploratory laparotomy
Abdominal surgery
???
???
???
???
???
57%
????????
???
??????
??
6.7%
??
??
????
?????
Ascites, Prothrombin time, albumin
Prothrombin time, systolic blood pressure, hemoglobin
Urgent surgery
Hepatic encephalopathy, ascites, albumin, hemoglobin
CTP score, Urgent surgery
CTP score
CTP Score
Hemoglobin, billirubin, malignancy
Table 4. Liver disease complication and effect in surgery????????
Liver disease complication Effect in surgery
Malnutrition Reduced muscle mass cause immobility, respiratory muscle dysfunction leading to prolonged 
mechanical ventilation, severe malnutrition cause impaired wound healing, increased risk infection
Coagulopathy Increased bleeding risk and need of blood transfusion
Ascites Increase the risk of abdominal wound dehiscence, abdominal wall herniation, and respiratory 
compromise
Renal dysfunction Increased risk morbidity and mortality
Portosystemic encephalopathy Post-operative immobility, lack of cooperation with nursing procedures and aspiration pneumonia
Pulmonary disorder Hipoxemia intraoperative
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Complications in patient with liver disease could 
increase the surgical morbidity and mortality risks. 
Management for these complications is very important 
to reduce surgical risk. This table on below showed 
management considerations for liver disease complications.
DISEASE SPECIFIC CONSIDERATION
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) 
encompasses a spectrum from bland steatosis, to 
nonalcoholic steatohepatitis (NASH), to cirrhosis. 
Patients with NAFLD but without cirrhosis do not 
seem to have increased mortality following elective 
surgery. Even though patients with NAFLD do not 
have an increased risk of perioperative mortality from 
their liver disease, this population is at higher risk 
for diabetes, hypertension, hypertriglyceridemia and 
coronary heart disease. As a result, preoperative cardiac 
????????????????????????????????8
Wilson's Disease
Patients using p-penicillamine should have the 
dose reduced before elective surgeries because it can 
interfere with wound healing.13
Autoimmune Liver Disease
Steroids are commonly used in patients with 
autoimmune conditions. Patients receiving steroids may 
require stress-dose steroids surrounding the perioperative 
period to prevent complications of hypotension.13
POSTOPERATIVE MONITORING
Postoperative monitoring in cirrhotic patients: (1) 
signs of liver failure such as encephalopathy, coagulation, 
ascites, jaundice, hypoglycemia(If these sign occur, the 
supportive treatment should be initiated and considered 
treatment in ICU. If encephalopathy occur then the 
factors which precipitate include gastrointestinal 
bleeding, anesthetic drugs, infection are considered); (2) 
renal function (BUN , Creatinin serum) and electrolytes; 
(3) liver synthetic function (PT, INR, albumin, glucose); 
???? ????????????????????????????????????????????????????
after intraabdominal surgery because this condition can 
precipitate Acute Kidney Injury; (5) use of furosemide, 
which should be cautiously considered because it can 
lead to intravascular hypovolemic; (6) limitation of 
?????????????????????????????????????????????????????????
which is highly recommended to prevent exacerbation 
of ascites or edema; (7) prevention of hypercarbia, 
whichrequired to prevent splanchnic vasodilation; and 
(8) the choice of analgesic drugs, which should be short 
acting analgetics such as fentanyl, while the use of 
acetaminophen is restricted < 2g/day.20
CONCLUSION
Many patients with liver disease would have to 
undergo surgery. Effect of surgery and anesthesia in these 
Table 5. Management consideration of complication in liver disease????????
Liver Disease Complication Management Consideration
Malnutrition ???????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????
Short term intravenous lipid is not recommended for liver chirrosis
?????????????????????????????????????????????????
Coagulopathy ???????????????????????????????????????????????
Fresh frozen plasma transfusion
???????????????????????????????????????????????????????? ??? ????????????????????????????????????????????
????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????3 based on type of surgery)
Ascites ?????????????????????????????????????????????????????????
Dietary sodium restriction (< 2 g daily)
????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????
Avoidance of excessive saline administration
???????????????????????????????????????????????????????????????????
Renal dysfunction Avoidance of NSAID, aminoglycoside, and intravenous contrast
Avoidance of nephrotoxic insult
Albumin infusion (with paracentesis volume > 5 L)
In HRS consider combination terlipressin with albumin/midodrine with ocreotide
Consider TIPS if other treatment failure
Portosystemic encephalopathy Correction of reversible metabolic factors
Avoidance of sedative and opioid narcotics, as far as possible
??????????????????????????????????????????????????????
Administration of non-absorpable antibiotics (neomicyne, rifaximin)
???????????????????????????????????????????????
Pulmonary disorder Supportive care, Oxygen supplementation
?????????????????????????????????????????????????????????
BCAA: branched-chain amino acid; SBP: Spontaneous bacterial peritonitis; TIPS: transjugular intrahepatic portosystemic shunt; NSAID: Non-steroidal anti-
????????????????????????????????? ??????????????
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patients associated with high perioperative complications 
???? ?????????? ???????????????????????????? ??????? ??????????
????????????????????????????????????????????????????????????
Comorbid condition; and (3) Timing & type of surgery. 
The greatest morbidity and mortality risks are found in 
emergency surgery, intra-abdominal surgery and cardiac 
surgery. CTP and MELD are two scoring systems which 
are often used to stratify risk factors in patients with liver 
cirrhosis who will undergo surgery. 
General guides to reduce morbidity and mortality 
included: identification of liver disease type, 
stratification of risk factors for timing and type 
of surgery, well management of preoperative, 
intraoperative, and postoperative complications. 
Preoperative complication managements including 
malnutrition, coagulopathy, ascites, renal dysfunction, 
portosystemic encephalopathy and pulmonary 
disorders and any conditions at disease specific 
consideration related to liver diseases. Intraoperative 
complication management related with anesthesia 
drugs choice and their effects to the liver. Postoperative 
monitoring including : signs of liver failure, renal 
?????????? ?????? ?????????? ?????????? ????? ?????? ???? ???
??????????????????????????????????????????????????????
hypercarbia and the choice of analgesic drugs.
REFERENCES
1. Rahimzadeh P, Safari S, Faiz SHR, Alavian SM. Anesthesia 
for Patients with Liver Disease. Hepat Mon 2014;7:79-81.
2. Henje AJ, Patel T. Perioperative Evaluation of Patients 
with Liver Disease. Nature Clinical Practice Gastroentero-
hepatology 2007;5:266-76.
3. Sanityoso A. Penyakit Hati. In: Mansjoer A, Sudoyo AW, 
Alwi I, Rinaldi I, Hrimurti K, Laksmi PW, Ranitya R, Setiati, 
eds. Kedokteran Perioperatif dan Tatalaksana di Bidang Ilmu 
Penyakit Dalam. Jakarta: Interna Publ 2007.p.207-15.
4. Mallet SV. Aneaesthesi and Liver Disease. In: Bircher J, 
Benhamou J, McIntyre N, Rizetto M, Rodes J, eds. Oxford 
Textbook of Clinical Hepatology. New York: Oxford 
University Press 1999.p.1012-20.
5. Nicoll M. Surgical Risk in Patient with Cirrhosis. Journal of 
Gastrology and Hepatology 2012;27:1569-75.
6. Suman A, Carey WD.Assessing the risk of surgery in patient 
with liver disease. Cleaveland Clinic Journal of Medicine 
2006;73:398-403.
7. Pandey CK, Karna ST, Pandey VK, Tandon M, Singhal 
A, Mangla V. Perioperatif Risk Factor in Patients With 
Liver Disease Undergoing Non-Hepatic Surgery. World J 
Gastrointest Surg 2012;4:267-74.
8. O’Leary JG, Friedman LS,Yachimski PS. Surgery in 
Patient with Liver Disease. Clinic Liver Disease. Elsivier 
2009;13:211-31.
9. Ziser A, Plevak DJ, Wiesner RH. Morbidity and mortality 
in cirrhotic patients undergoing anesthesia and surgery. 
Anesthesiology 1999;90:42–93.
10. Ahmed A, Martin P. Assesing and Managing Hepatobiliary 
Disease. In: Jaffer AK, Grant PJ, eds. Perioperative Medicine: 
Medical Consultation and Co-Management. Canada: Wiley-
Blackwell 2012.p149-61.
11. Howdle PD. History and Physical Examination. In: Bacon 
?????? ??????????????????? ???????????????????????????????
Clinical Hepatology Second Edition. China: Elsevier 2006. p. 64.
12. Keegan MT, Plevak DJ.Perioperatif Assessment of The Patient 
with Liver Disease. Am J Gastroenterol 2005;100:2116-27.
13. ???????????????????????????????????????? ?????????????????
Evaluation of The Patient With Known or Suspected Liver 
DIsease. Clinical Liver Disease 2016;7: 101-105.
14. Rizvon MK, Chou CL. Surgery in the patient with liver 
disease. Med Clin North Am Jan 2003;87:211-27.
15. Bhangui P, Laurent A, Amatheiu R, Azoulay D. Assessment of 
Risk for Non-Hepatic Surgery in Chirrotic Patients. J Hepatol 
2012;57:874-84.
16. Vaja R, McNicol L, Sisley I. 2010. Anesthesia for Patients with 
Liver Disease. Continuing Education in Anesthesia, Critical 
Care & Pain 2010;10:15-9.
17. Teh SH, Nargoney DM, Stevens SR. 2007. Risk Factor 
for Mortality After Surgery in Patients with Cirrhosis. 
Gastroenterology 2007;132:1261-9.
18. Merli M, Nicolini G, Angeloni S. Malnutrition is a Risk 
Factor in Cirrhotic Patients Undergoing Surgery. Nutrition 
2002;18:978-86.
19. Milwala F, Nguyen GC, Thuluvat PJ. Outcomes of Patients 
with Cirrhosis Undergoing Non-Hepatic Surgery: Risk 
Assessment and Management. World J Gastroenterol 
2007;13:4056-63.
20. Mitchel KJ. Liver Disease and Perioperative Risk. In: Wong 
CJ, Hamlin NP, eds. The Perioperative Medicine Consult 
Handbook. New York: Springer 2013.p.135-9.
